gimli
ZYDUSLIFE stock analysis context
ZYDUS LIFESCIENCES Stock Context for AI Screening
ZYDUS LIFESCIENCES LTD is a mid-cap stock in Healthcare. This page summarizes key screening signals for ZYDUS LIFESCIENCES, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Ask Gimli about ZYDUSLIFEPrice
₹1,038.95
1M return
+11.73%
3M return
+15.34%
Market cap
₹104,542.68 cr
PE
22.23
ROE
+19.41%
RSI
69.40
Turnover
₹134.66 cr
Why it can matter in screens
- Momentum: ZYDUSLIFE is above 50DMA, above 200DMA; RSI is 69.40.
- Returns: 1M +11.73%, 3M +15.34%, 6M +12.40%.
- Liquidity: latest turnover is ₹134.66 cr.
- Valuation: PE 22.23, PB n/a, ROE +19.41%, ROCE +24.32%.
- Growth: 3Y sales CAGR +15.04%, 3Y profit CAGR +0.28%.
Try these prompts
- Analyze ZYDUS LIFESCIENCES with valuation, momentum and industry peers
- Compare ZYDUSLIFE with other Healthcare stocks
- Show mid-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View mid-cap stocks
- Find stocks above 50DMA
- Compare ZYDUSLIFE with other Healthcare stocks
Data snapshot: 2026-05-22. Not investment advice.